Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P53 AND CYCLIN B1 MEDIATE APOPTOTIC EFFECTS OF APIGENIN AND RUTIN IN ER+-BREAST CANCER MCF-7 CELLS

View through CrossRef
Tamoxifen is an effective treatment for estrogen receptor alpha positive (ERa+)-breast cancer, however patients who received the treatment for five years have greater mortality risk compared to those who did not receive tamoxifen. Furthermore, patients treated with tamoxifen developed resistance to the drug which mediated through p53 and PTEN. Therefore, the study is undertaken to determine the potential adjuvant properties of flavonoids, apigenin and rutin to promote the anticancer activity induced by tamoxifen using ERa+-breast cancer MCF-7 cell lines. MCF-7 and non-transformed breast MCF-10A cells were treated separately with apigenin, rutin, tamoxifen or the combination of each flavonoids with tamoxifen. Anti-proliferative activity and respective IC50 concentrations were determined using MTT assay. The respective IC50 concentrations obtained were used in the subsequent experiments. The anti-proliferative mechanism was determined using Annexin V-FITC morphological staining and DNA fragmentation assays. The effect on tumor suppressor (p53 and PTEN) and cell cycle related genes (p21, CDK1 and Cyclin B1) were determined by QuantiGene Plex assay. Our results showed that MCF-7 cells were more sensitive to both apigenin and rutin compared to MCF-10A cells. Both cells were sensitive to tamoxifen. Apigenin and rutin synergistically enhanced tamoxifen anti-proliferative effect in MCF-7. Meanwhile rutin protects MCF-10A against the toxicity of tamoxifen. Our results indicate that the anti-proliferative mechanism of apigenin and rutin is mediated by apoptosis signals. In MCF-7 cells, both tumor suppressor (p53 and PTEN) and cell cycle related genes (p21 and CDK1) were up regulated by apigenin and rutin, contrary to tamoxifen. Apigenin and rutin induced G2/M arrest and apoptosis in MCF-7 cells through p53-dependent pathway. Both flavonoids are suggested as potential adjuvant agents to enhance tamoxifen efficacy in ERa+-breast cancer treatment.  
Title: P53 AND CYCLIN B1 MEDIATE APOPTOTIC EFFECTS OF APIGENIN AND RUTIN IN ER+-BREAST CANCER MCF-7 CELLS
Description:
Tamoxifen is an effective treatment for estrogen receptor alpha positive (ERa+)-breast cancer, however patients who received the treatment for five years have greater mortality risk compared to those who did not receive tamoxifen.
Furthermore, patients treated with tamoxifen developed resistance to the drug which mediated through p53 and PTEN.
Therefore, the study is undertaken to determine the potential adjuvant properties of flavonoids, apigenin and rutin to promote the anticancer activity induced by tamoxifen using ERa+-breast cancer MCF-7 cell lines.
MCF-7 and non-transformed breast MCF-10A cells were treated separately with apigenin, rutin, tamoxifen or the combination of each flavonoids with tamoxifen.
Anti-proliferative activity and respective IC50 concentrations were determined using MTT assay.
The respective IC50 concentrations obtained were used in the subsequent experiments.
The anti-proliferative mechanism was determined using Annexin V-FITC morphological staining and DNA fragmentation assays.
The effect on tumor suppressor (p53 and PTEN) and cell cycle related genes (p21, CDK1 and Cyclin B1) were determined by QuantiGene Plex assay.
Our results showed that MCF-7 cells were more sensitive to both apigenin and rutin compared to MCF-10A cells.
Both cells were sensitive to tamoxifen.
Apigenin and rutin synergistically enhanced tamoxifen anti-proliferative effect in MCF-7.
Meanwhile rutin protects MCF-10A against the toxicity of tamoxifen.
Our results indicate that the anti-proliferative mechanism of apigenin and rutin is mediated by apoptosis signals.
In MCF-7 cells, both tumor suppressor (p53 and PTEN) and cell cycle related genes (p21 and CDK1) were up regulated by apigenin and rutin, contrary to tamoxifen.
Apigenin and rutin induced G2/M arrest and apoptosis in MCF-7 cells through p53-dependent pathway.
Both flavonoids are suggested as potential adjuvant agents to enhance tamoxifen efficacy in ERa+-breast cancer treatment.
 .

Related Results

Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract The tumor suppressor p53 is mutated in more than 50% of all cancers. The transcriptional activity of p53 depends on localization to the nucleus and formatio...
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 2958: Cyclin D1 regulates the ARF and INK4a promoters
Abstract 2958: Cyclin D1 regulates the ARF and INK4a promoters
Abstract Cyclin D1 is a member of cyclin protein family, which drives the cell cycle transition from G1 to S phase. The cyclin D1 protein is overexpressed in ∼50% of...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...

Back to Top